Can ebselen prevent cisplatin-induced ovarian damage?

Biological and biomechanical analysis of two types of mesenchymal stem cells for intervention in chemotherapy-induced ovarian dysfunction

(2016) Yuan Pan et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress

(2015) XIAOYIN MENG et al.   Experimental and Therapeutic Medicine

Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model

(2014) Ali Akdemir et al.   Journal of Gynecologic Oncology

Oxytocin Improves Follicular Reserve in a Cisplatin-Induced Gonadotoxicity Model in Rats

(2014) Oytun Erbaş et al.   Biomed Research International

The early research and development of ebselen

(2013) Michael J. Parnham et al.   BIOCHEMICAL PHARMACOLOGY

Cisplatin and Doxorubicin Induce Distinct Mechanisms of Ovarian Follicle Loss; Imatinib Provides Selective Protection Only against Cisplatin

(2013) Stephanie Morgan et al.   PLoS One

A safe lithium mimetic for bipolar disorder

(2013) Nisha Singh et al.   Nature Communications

Pretreatment Serum Anti-Müllerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer

(2011) Richard A. Anderson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist

(2009) Bulent Ozcelik et al.   FERTILITY AND STERILITY

Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells

(2009) Se-Jin Kim et al.   HEARING RESEARCH

Ebselen attenuates cyclophosphamide-induced oxidative stress and DNA damage in mice

(2008) D. N. Tripathi et al.   FREE RADICAL RESEARCH

Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?

(2008) B. D. Lawenda et al.   JNCI-Journal of the National Cancer Institute